1-Evolving Paradigm In The Treatment Of Type 2 Diabetes

Boehringer Ingelheim


Content
  • Lecture Title
  • Learning Objectives
  • dr.abdul raouf al mahfouz_2.mp4
  • Question-Empagliflozin has been shown to reduce cardiovascular
Completion rules
  • All units must be completed